曲妥珠单抗生物仿制药ABP 980在不同温度、浓度和应激条件下的静脉袋制备、运输和储存后与参比产品的稳定性

IF 0.3 Q4 PHARMACOLOGY & PHARMACY

GaBI Journal-Generics and Biosimilars Initiative Journal Pub Date : 2020-03-15 DOI:10.5639/gabij.2020.0901.002

Shon Crampton, A. Polozova, Darin Asbury, Alexis M K Lueras, P. Breslin, J. Hippenmeyer, J. Litowski, Monica Goss

引用次数: 6

摘要

第9卷| 2020 |第1期| 5通信作者:Shon Crampton, BA, Scientist, Amgen Inc, 360 Binney Street, Cambridge, MA 02142, USA

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Stability of the trastuzumab biosimilar ABP 980 compared to reference product after intravenous bag preparation, transport and storage at various temperatures, concentrations and stress conditions

Volume 9 | 2020 | Issue 1 | 5 Author for correspondence: Shon Crampton, BA, Scientist, Amgen Inc, 360 Binney Street, Cambridge, MA 02142, USA

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

GaBI Journal-Generics and Biosimilars Initiative Journal PHARMACOLOGY & PHARMACY-

CiteScore

1.80

自引率

0.00%

发文量

期刊介绍： The scope of GaBI Journal is broad and of interest and relevance to professionals active in clinical practice, pharmaceutical science and policy. Materials published in GaBI Journal include high quality research reports, literature reviews and case studies, all of which are peer reviewed. Manuscripts on all aspects of generic and biosimilar medicines, covering areas in clinical, fundamental, technical, manufacturing, bi-processing, economic and social aspects of pharmaceuticals and therapeutics are welcome. In addition, high quality work submitted in other formats, for example, scientific and evidence-based commentaries, may also be considered. In all cases, the emphasis is on quality, originality and knowledge contribution to those involved in health care. All manuscripts submitted to GaBI Journal are subject to a rigorous peer review process. GaBI Journal plans to be indexed in PubMed within two years, and that indexing will be retrospective. GaBI Journal is published quarterly from 2012. All articles are published in English.